Your session is about to expire
← Back to Search
Trigger Timing in Controlled Ovarian Stimulation for Female Infertility
Study Summary
This trial will compare the efficacy of two different times of administration of medications for final oocyte maturation, commonly called a "trigger", in cycles of controlled ovarian stimulation.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had IVF before, but I haven't collected eggs more than once in this study.My tests show I have a normal or better chance of producing eggs.I am a woman between 18 and 35 years old planning IVF with embryo freezing.My tests show I have a normal or better chance of producing eggs.I am a woman between 18 and 35 years old planning IVF with embryo freezing.
- Group 1: Early Trigger
- Group 2: Delayed trigger
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this clinical trial accessible to individuals aged 25 and above?
"The age range for participants in this trial is between 18 and 34 years old."
How many individuals are participating in this research project?
"Affirmative. According to clinicaltrials.gov, the recruitment process for this medical trial is still ongoing since its original posting on August 10th 2022 and subsequent update. The goal is to enlist 150 individuals from a single location."
What criteria must a participant meet in order to qualify for this research?
"This research study requires 150 participants of childbearing age, aged 18 to 34. All candidates must meet the following criteria: female adults who plan on undergoing in-vitro fertilization (IVF), with at least 8 antral follicles observed via ultrasound scan or a serum AMH level of 1.5 ng/ml; have basic literacy proficiency in English for informed consent purposes; and can only participate once if they had prior IVF cycles."
Is registration for this clinical trial currently open?
"Correct. The information hosted on clinicaltrials.gov suggests that recruitment for this medical trial, which was first posted on August 10th 2022, is currently in progress. Approximately 150 individuals have to be recruited from 1 site specifically."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Average response time
- < 2 Days
Most responsive sites:
- Fertility center of Las Vegas: < 48 hours
Share this study with friends
Copy Link
Messenger